(RTTNews) - Sartorius AG (SARTF, SRT.DE), a German pharmaceutical and lab equipment company, reported Thursday higher profit in the first nine months of fiscal 2026, driven by sales growth. Further, the firm maintained fiscal 2026 outlook.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.
